89bio, Inc.
News
NANOBIOTIX Announces Two Key Supervisory Board Additions Intended to Further Equip the Company for Sustainable Long-Term Growth
Globe Newswire Dr. Margaret A. Liu, global expert in vaccines, gene therapy, and cancer immunotherapy; chief executive officer of PAX Therapeutics and member of several boardsMs. Anat Naschitz, proven life science...\n more…
Short Interest in 89bio, Inc. (NASDAQ:ETNB) Rises By 5.2%
Ticker Report 89bio, Inc. (NASDAQ:ETNB - Get Free Report) saw a significant increase in short interest in August. As of August 15th, there was short interest totalling 6,840,000 shares, an increase of 5.2% from...\n more…
89bio to Participate in Upcoming Investor Conferences
Globe Newswire SAN FRANCISCO, Aug. 29, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for...\n more…
89bio, Inc. (NASDAQ:ETNB) Given Consensus Rating of "Moderate Buy" by Brokerages
Ticker Report Shares of 89bio, Inc. (NASDAQ:ETNB - Get Free Report) have received a consensus rating of "Moderate Buy" from the eight brokerages that are currently covering the company, MarketBeat Ratings reports...\n more…
SG Americas Securities LLC Acquires New Holdings in 89bio, Inc. (NASDAQ:ETNB)
Ticker Report SG Americas Securities LLC bought a new position in 89bio, Inc. (NASDAQ:ETNB - Free Report) in the second quarter, according to the company in its most recent disclosure with the SEC. The fund bought...\n more…